PGLA (Progen Industries Limited)

Health Care (Pharmaceuticals and Biotechnology)

Investment Models With Most Exposure In This Sector

Manager

Model

Sector Exposure

Since Inception

Sub. Fee

Sector FocusInception Jan 17, 2011

The U.S. healthcare industry, particularly Biotech and MedTech, is the core investment universe of my strategy.

View Free Trial
Sector FocusInception Oct 06, 2010

A portfolio of healthcare companies managed to identify growth and preserve capital with maximum of 20 positions and minimum of 5 …

View Free Trial
OpportunisticInception Mar 23, 2011

Opportunistic: emphasis on high-tech, Asian ADRs, and beaten-down stocks.

View Free Trial

James Roberts

Best Ideas (J:RBIX)

21.87%

10.39%

1.10%

OpportunisticInception Aug 11, 2011

This model draws information from the other two models but is not restricted to those sources.  Most investment candidates will …

View Free Trial
Market TimingInception Dec 13, 2010

The model uses quantitative analysis to find short term overbought and oversold conditions in equities.The model has low …

View Free Trial

PGLA News

Loading...

Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.

Important Information

  1. Past performance is no guarantee of future results.
  2. Performance of the model manager’s account is calculated by Covestor on a daily time-weighted basis, including cash and broker commissions. Manager returns include trades that fail Covestor’s trading rules, do not reflect any Covestor suitability or risk score restrictions and are exclusive of Covestor fees. More
  3. Month to Date returns and Since Inception returns are revised daily. All other returns (month, 3 month, year to date, et al) are calculated as of the most recent month end date.
  4. The subscription fee range between 0.5%-2.30% p.a. per subscription to a model. They are subject to a $12.50 minimum per subscription per month, whether or not any trade activity occurs. No subscripition fees are charged on cash that is not subscribed to models
  5. Benchmark returns have been calculated by Covestor using a time-weighted calculation of daily index valuations and do not include cash or transaction costs.
  6. All Model Manager information including personal data, profiles, strategies, monthly investment reports, and historical results outside of Covestor has been provided by the Model Manager. Covestor makes no representation or warranty of its accuracy, completeness or relevance and it does not represent the opinions of Covestor. Transaction history is available upon reques.